Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
As CEO, my guiding principle in this crisis is simple: You cannot manage a balance sheet if you destroy your soul, and you cannot protect shareholders by killing patients. Delaying disclosure of a fatal side effect to protect a stock price is not only a profound ethical failure; it is corporate suicide.Read the full answer
You have a patient safety issue, not a PR issue. The 6 month regulatory reporting timeline is the formal process, not the ethical or legal obligation to act now. Waiting for more data while patients continue to be exposed is criminal negligence exposure, not risk mitigation.Read the full answer